Can propranolol prevent progression of melanoma?

Jason Kao, Brent Luu

Research output: Contribution to journalArticle

Abstract

The worldwide incidence of melanoma has risen rapidly in the past 50 years and is a considerable public health burden in the United States, with significant financial implications. Studies have demonstrated the potential anticarcinogenic effects of antihypertensive agents, specifically beta-blockers, in patients with prostate cancer, breast cancer, and lately cutaneous malignant melanoma. This article explores the empirical clinical evidence of propranolol's anticarcinogenic effects on melanoma and the chemoprotective mechanisms of beta-blockers and other agents that have been used to modify melanoma progression.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalJAAPA : official journal of the American Academy of Physician Assistants
Volume32
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Propranolol
Anticarcinogenic Agents
Melanoma
Breast Neoplasms
Skin Neoplasms
Antihypertensive Agents
Prostatic Neoplasms
Public Health
Incidence
Cutaneous Malignant Melanoma

ASJC Scopus subject areas

  • Nurse Assisting

Cite this

Can propranolol prevent progression of melanoma? / Kao, Jason; Luu, Brent.

In: JAAPA : official journal of the American Academy of Physician Assistants, Vol. 32, No. 6, 01.06.2019, p. 1-5.

Research output: Contribution to journalArticle

@article{ae9ce1238c8d4d70b2ca2c530b1403a6,
title = "Can propranolol prevent progression of melanoma?",
abstract = "The worldwide incidence of melanoma has risen rapidly in the past 50 years and is a considerable public health burden in the United States, with significant financial implications. Studies have demonstrated the potential anticarcinogenic effects of antihypertensive agents, specifically beta-blockers, in patients with prostate cancer, breast cancer, and lately cutaneous malignant melanoma. This article explores the empirical clinical evidence of propranolol's anticarcinogenic effects on melanoma and the chemoprotective mechanisms of beta-blockers and other agents that have been used to modify melanoma progression.",
author = "Jason Kao and Brent Luu",
year = "2019",
month = "6",
day = "1",
doi = "10.1097/01.JAA.0000558241.84003.91",
language = "English (US)",
volume = "32",
pages = "1--5",
journal = "Journal of the American Academy of Physician Assistants",
issn = "1547-1896",
publisher = "American Academy of Physicians Assistants",
number = "6",

}

TY - JOUR

T1 - Can propranolol prevent progression of melanoma?

AU - Kao, Jason

AU - Luu, Brent

PY - 2019/6/1

Y1 - 2019/6/1

N2 - The worldwide incidence of melanoma has risen rapidly in the past 50 years and is a considerable public health burden in the United States, with significant financial implications. Studies have demonstrated the potential anticarcinogenic effects of antihypertensive agents, specifically beta-blockers, in patients with prostate cancer, breast cancer, and lately cutaneous malignant melanoma. This article explores the empirical clinical evidence of propranolol's anticarcinogenic effects on melanoma and the chemoprotective mechanisms of beta-blockers and other agents that have been used to modify melanoma progression.

AB - The worldwide incidence of melanoma has risen rapidly in the past 50 years and is a considerable public health burden in the United States, with significant financial implications. Studies have demonstrated the potential anticarcinogenic effects of antihypertensive agents, specifically beta-blockers, in patients with prostate cancer, breast cancer, and lately cutaneous malignant melanoma. This article explores the empirical clinical evidence of propranolol's anticarcinogenic effects on melanoma and the chemoprotective mechanisms of beta-blockers and other agents that have been used to modify melanoma progression.

UR - http://www.scopus.com/inward/record.url?scp=85067306117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067306117&partnerID=8YFLogxK

U2 - 10.1097/01.JAA.0000558241.84003.91

DO - 10.1097/01.JAA.0000558241.84003.91

M3 - Article

C2 - 31136408

AN - SCOPUS:85067306117

VL - 32

SP - 1

EP - 5

JO - Journal of the American Academy of Physician Assistants

JF - Journal of the American Academy of Physician Assistants

SN - 1547-1896

IS - 6

ER -